BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9153302)

  • 1. A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II.
    Bourquin JP; Stagljar I; Meier P; Moosmann P; Silke J; Baechi T; Georgiev O; Schaffner W
    Nucleic Acids Res; 1997 Jun; 25(11):2055-61. PubMed ID: 9153302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins.
    Yuryev A; Patturajan M; Litingtung Y; Joshi RV; Gentile C; Gebara M; Corden JL
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6975-80. PubMed ID: 8692929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel SR-related protein specifically interacts with the carboxy-terminal domain (CTD) of RNA polymerase II through a conserved interaction domain.
    Tanner S; Stagljar I; Georgiev O; Schaffner W; Bourquin JP
    Biol Chem; 1997 Jun; 378(6):565-71. PubMed ID: 9224939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nuclear matrix protein interacts with the phosphorylated C-terminal domain of RNA polymerase II.
    Patturajan M; Wei X; Berezney R; Corden JL
    Mol Cell Biol; 1998 Apr; 18(4):2406-15. PubMed ID: 9528809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the C-terminal domain of novel human SR-A1 protein: interaction with the CTD domain of RNA polymerase II.
    Katsarou ME; Papakyriakou A; Katsaros N; Scorilas A
    Biochem Biophys Res Commun; 2005 Aug; 334(1):61-8. PubMed ID: 15992770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AtCyp59 is a multidomain cyclophilin from Arabidopsis thaliana that interacts with SR proteins and the C-terminal domain of the RNA polymerase II.
    Gullerova M; Barta A; Lorkovic ZJ
    RNA; 2006 Apr; 12(4):631-43. PubMed ID: 16497658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II.
    Morris DP; Greenleaf AL
    J Biol Chem; 2000 Dec; 275(51):39935-43. PubMed ID: 10978320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD.
    Emili A; Shales M; McCracken S; Xie W; Tucker PW; Kobayashi R; Blencowe BJ; Ingles CJ
    RNA; 2002 Sep; 8(9):1102-11. PubMed ID: 12358429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of Arabidopsis RS domain containing cyclophilins with SR proteins and U1 and U11 small nuclear ribonucleoprotein-specific proteins suggest their involvement in pre-mRNA Splicing.
    Lorkovic ZJ; Lopato S; Pexa M; Lehner R; Barta A
    J Biol Chem; 2004 Aug; 279(32):33890-8. PubMed ID: 15166240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of RNA polymerase II CTD fragments results in tight binding to the WW domain from the yeast prolyl isomerase Ess1.
    Myers JK; Morris DP; Greenleaf AL; Oas TG
    Biochemistry; 2001 Jul; 40(29):8479-86. PubMed ID: 11456485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics studies of the interactome of RNA polymerase II C-terminal repeated domain.
    Pineda G; Shen Z; de Albuquerque CP; Reynoso E; Chen J; Tu CC; Tang W; Briggs S; Zhou H; Wang JY
    BMC Res Notes; 2015 Oct; 8():616. PubMed ID: 26515650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing.
    Yang L; Chansky HA; Hickstein DD
    J Biol Chem; 2000 Dec; 275(48):37612-8. PubMed ID: 10982800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA.
    Kim E; Du L; Bregman DB; Warren SL
    J Cell Biol; 1997 Jan; 136(1):19-28. PubMed ID: 9008700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions.
    Sánchez-Alvarez M; Goldstrohm AC; Garcia-Blanco MA; Suñé C
    Mol Cell Biol; 2006 Jul; 26(13):4998-5014. PubMed ID: 16782886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.
    Xiao H; Lis JT; Xiao H; Greenblatt J; Friesen JD
    Nucleic Acids Res; 1994 Jun; 22(11):1966-73. PubMed ID: 8029001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospho-carboxyl-terminal domain binding and the role of a prolyl isomerase in pre-mRNA 3'-End formation.
    Morris DP; Phatnani HP; Greenleaf AL
    J Biol Chem; 1999 Oct; 274(44):31583-7. PubMed ID: 10531363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
    Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
    EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing.
    Du L; Warren SL
    J Cell Biol; 1997 Jan; 136(1):5-18. PubMed ID: 9008699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrin CYP, an SR-rich cyclophilin that associates with the nuclear matrix and splicing factors.
    Mortillaro MJ; Berezney R
    J Biol Chem; 1998 Apr; 273(14):8183-92. PubMed ID: 9525923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.